The effect of cannabidiol on simulated car driving performance: A randomised, double‐blind, placebo‐controlled, crossover, dose‐ranging clinical trial protocol

Objective Interest in the use of cannabidiol (CBD) is increasing worldwide as its therapeutic effects are established and legal restrictions moderated. Unlike Δ9‐tetrahydrocannabinol (Δ9‐THC), CBD does not appear to cause cognitive or psychomotor impairment. However, further assessment of its effect...

Ausführliche Beschreibung

Gespeichert in:

Bibliographische Detailangaben
Veröffentlicht in:	Human psychopharmacology 2020-09, Vol.35 (5), p.e2749-n/a
Hauptverfasser:	McCartney, Danielle, Benson, Melissa J., Suraev, Anastasia S., Irwin, Christopher, Arkell, Thomas R., Grunstein, Ronald R., Hoyos, Camilla M., McGregor, Iain S.
Format:	Artikel
Sprache:	eng
Schlagworte:	Automobile Driving Cannabidiol Cannabidiol - administration & dosage Cannabidiol - adverse effects Cannabinoids Clinical trials cognition Cognition - drug effects Cognitive ability Cross-Over Studies Dose-Response Relationship, Drug Double-Blind Method Double-blind studies driving simulation Humans medicinal cannabis mobile drug testing psychomotor Randomized Controlled Trials as Topic Tetrahydrocannabinol Time Factors
Online-Zugang:	Volltext
Tags:	Tag hinzufügen Keine Tags, Fügen Sie den ersten Tag hinzu!

Schreiben Sie den ersten Kommentar!